Skip to content

← All developments

PACER filings: 42 U.S.C. § 1320a-7b (AKS) · October 22, 2026 · Primary source

United States v. COMMUNITY HOME HEALTH CARE LLC

Score 87PRIMARYregulatoryFederal courtME

What the document says

A federal grand jury in the District of Maine returned an indictment, filed October 22, 2026, charging Community Home Health Care LLC and multiple individual defendants, including Mohammed Alkhalaf (a/k/a Abu Stayf), Ethar Alyaseen, and Sura Almohammed (a/k/a Um Ayman), under Case No. 1:26-cr-00114-JAW. The charges as set out in the arrest warrant for Alkhalaf are Count 1: healthcare fraud conspiracy under 18 U.S.C. sections 1349 and 1347, and Count 2: false statements under 18 U.S.C. section 1001. Alkhalaf was arrested on October 27, 2026, in Augusta, Maine, pursuant to a warrant issued October 22, 2026. Alyaseen and Almohammed were also processed before the magistrate court on October 27, 2026. All three individual defendants were released on unsecured appearance bonds of $10,000 each, subject to standard pretrial conditions including no contact with co-defendants or witnesses except as specifically carved out. The court's amended procedural order sets a schedule in which all pretrial motions by defendants are due no later than November 10, 2026, with expert witness disclosures required no later than 20 days before trial. Trial before Judge John A. Woodcock Jr. is scheduled to commence December 3, 2026. The indictment names Community Home Health Care LLC as a principal defendant, with the individual defendants charged as participants in the alleged healthcare fraud conspiracy. No dollar amount of alleged fraudulent claims or the specific federal healthcare program targeted is identified in the docket entries available.

What this may mean

Applies to home health agencies operating under federal healthcare billing authority. The indictment under 18 U.S.C. sections 1347 and 1349 puts home health agency entities and their principals at issue for criminal healthcare fraud conspiracy and false statement exposure. Trial is set for December 3, 2026.

Informational only. Not legal, medical, financial, or other professional advice. Always consult a qualified professional familiar with your specific facts before relying on any item.

Related items